Diabetes results in structural alteration of chondroitin sulfate/dermatan sulfate in the rat kidney: Effects on the binding to extracellular matrix components

Glycobiology

Volumn 21, Issue 7, 2011, Pages 960-972

  Joladarashi, Darukeshwara ^a   Salimath, Paramahans V ^a   Chilkunda, Nandini D ^a  

^a CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

Author keywords

chondroitin sulfate; dermatan sulfate; diabetes; E disaccharide unit; extracellular matrix components

Indexed keywords

CHONDROITIN SULFATE; COLLAGEN TYPE 4; DERMATAN SULFATE; FIBRONECTIN; HEPARAN SULFATE; LAMININ; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; GENE EXPRESSION; IN VITRO STUDY; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ANALYSIS; SULFATION;

ANIMALS; BLOTTING, WESTERN; CHONDROITIN SULFATES; DERMATAN SULFATE; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; EXTRACELLULAR MATRIX; KIDNEY; MALE; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFOTRANSFERASES;

RATTUS;

EID: 79958827062     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwr029     Document Type: Article

References (57)

1. Bakalash S, Rolls A, Lider O, Schwartz M. 2007. Chondroitin sulfate-derived disaccharide protects retinal cells from elevated intraocular pressure in aged and immunocompromised rats. Invest Ophthalmol Vis Sci. 48:1181-1190. (Pubitemid 351261413)
2. Bao X, Muramatsu T, Sugahara K. 2005. Demonstration of the pleiotrophin-binding oligosaccharide sequences isolated from chondroitin sulfate/derma-tan sulfate hybrid chains of embryonic pig brains. J Biol Chem. 280:35318-35328. (Pubitemid 41532720)
3. Barkalow FJ, Schwarzbaver JF. 1994. Interaction between fibronectin and chondroitin sulphate are modulated by molecular context. J Biol Chem. 276:3957-3962. (Pubitemid 24237740)
4. Bechard D, Gentina T, Delehedde M, Scherpereel A, Lyon M, Aumercier M, Vazeux R, Richet C, Degand P, Jude B, et al. 2001. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem. 276:48341-48349.
5. Bieri JG, Stoewsand GS, Briggs GM, Phillips RW, Woolard JC, Knapka JJ. 1997. Report of the American institute of nutrition, Ad Hoc committee on standards for nutritional studies. J Nutr. 107:1340-1348.
6. Bigge JC, Patel TP, Bruce JA, Goulding PN, Charles SM, Parekh RB. 1995. Non-selective and efficient fluorescent labeling of glycans using 2-aminobenzamide and anthranilic acid. Anal Biochem. 230:229-238.
7. Bjornsson S. 2000. Detection of epitopes in glycosaminoglycans immobilized on hydrophobic membranes. Scand J Clin Lab Invest. 233:27-36.
8. Cadaval RA, Kohlman O, Michelacci YM. 2000. Urinary excretion of glyco-saminoglycans and albumin in experimental diabetes mellitus. Glycobiology. 10:185-192. (Pubitemid 30193019)
9. Chandrasekhar S, Esterman MA, Hoffman H. 1987. A microdetermination of proteoglycan and glycosaminoglycans in the presence of guanidine hydro-chloride. Anal Biochem. 161:103-108. (Pubitemid 17036695)
10. Chen RL, Lander AD. 2001. Mechanisms underlying preferential assembly of heparan sulfate on glypican-1. J Biol Chem. 276:7507-7517.
11. Deepa SS, Umehara Y, Higashiyam S, Itoh N, Sugahara K. 2002. Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues. J Biol Chem. 277:43707-43716. (Pubitemid 36157787)
12. Dinglasan RR, Alaganan A, Ghosh AK, Saito A, van Kuppevelt TH, Jacobs-Lorena M. 2007. Plasmodium falciparum ookinetes require mosquito midgut chondroitin sulfate proteoglycans for cell invasion. Proc Natl Acad Sci USA. 104:15882-15887. (Pubitemid 350035393)
13. Ehara T, Carone FA, McCarthy KJ, Couchman JR. 1994. Basement membrane chondroitin sulfate proteoglycan alterations in a rat model of poly-cystic kidney disease. Am J Pathol. 144:612-621. (Pubitemid 24176767)
14. Farndale RW, Buttle DJ, Barrett AJ. 1986. Improved quantitation and discrimination of sulfated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 883:173-177. (Pubitemid 16027978)
15. Fowler MJ. 2008. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 26:77-82. (Pubitemid 351556223)
16. Ferro DR, Provasoli A, Ragazzi M, Torri G, Casu B, Gatti G, Jacquinet JC, Sinay P, Petitou M, Choay J. 1986. Evidence for conformational equilibrium of the sulfated l-iduronate residue in heparin and in synthetic heparin monosaccharides and oligosaccharides-NMR and force-field studies. J Am Chem Soc. 108:6773-6778. (Pubitemid 16006206)
17. Gamain B, Gratepanche S, Miller LH, Baruch DI. 2002. Molecular basis for the dichotomy in Plasmodium falciparum adhesion to CD36 and chondroi-tin sulfate A. Proc Natl Acad Sci USA. 99:10020-10024. (Pubitemid 34831165)
18. Hatch GM, Cao SG, Angel A. 1995. Decrease in cardiac phosphatidyl gly-cerol in streptozotocin induced diabetic rats does not affect cardiolipin biosynthesis. Evident for distant pools of phospolipid glycerol in the heart. Biochem J. 306:759-764.
19. Hileman RE, Fromm JR, Weiler JM, Linhardt RJ. 1998. Glycosaminoglycan- protein interactions: Definition of consensus sites in glycosaminoglycans binding proteins. BioEssays. 20:156-167. (Pubitemid 28132111)
20. Ito Y, Habuchi O. 2000. Purification and characterization of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase from the squid cartilage. J Biol Chem. 275:34728-34736.
21. Jane FT, Zeynep A, Walter G, Andrea B, Timpl R. 1999. Binding of the G domains of laminin α-1 and α-2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins. EMBO J. 18:863-870. (Pubitemid 29082266)
22. Jeansson M, Haraldsson B. 2003. Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes. J Am Soc Nephrol. 14:1756-1765. (Pubitemid 36750471)
23. Kinoshita A, Sugahara K. 1999. Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: Application to disaccharide composition analysis and exosequencing of oligosaccharides. Anal Biochem. 269:367-378. (Pubitemid 29201038)
24. Kjellen L, Lindahl U. 1991. Proteoglycans: Structures and interactions. Annu Rev Biochem. 60:443-475.
25. Lane MC, Solursh M. 1991. Primary mesenchyme cell migration requires a chondroitin sulfate/dermatan sulfate proteoglycan. Dev Biol. 143:389-397. (Pubitemid 121004664)
26. Maccarana M, Kalamajski S, Kongsgaard M, Magnusson SP, Oldberg A, Malmstrom A. 2009. Dermatan sulfate epimerase-1 deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin. Mol Cell Biol. 29:5517-5528.
27. McCarthy KJ, Abrahamson DR, Bynum KR, St John PL, Couchman JR. 1994. Basement membrane-specific chondroitin sulfate proteoglycan is abnormally associated with the glomerular capillary basement membrane of diabetic rats. J Histochem Cytochem. 42:473-484. (Pubitemid 24090007)
28. Nandini CD, Itoh N, Sugahara K. 2005. Novel 70-kDa chondroitin sulfate/ dermatan sulfate hybrid chains with a unique heterogenous sulfation pattern from shark skin, which exhibit neuritogenic activity and binding activities for growth factors and neurotrophic factors. J Biol Chem. 280:4058-4069. (Pubitemid 40288569)
29. Nandini CD, Mikami T, Ohta M, Itoh N, Akiyama-Nambu F, Sugahara K. 2004. Structural and functional characterization of oversulfated chondroitin sulfate/dermatan sulfate hybrid chains from the notochord of hagfish neuri-togenic and binding activities for growth factors and neurotrophic factors. J Biol Chem. 279:50799-50809. (Pubitemid 40017818)
30. Nandini CD, Sambaiah K, Salimath PV. 2003. Dietary fibres ameliorate decreased synthesis of heparan sulfate in streptozotocin induced diabetic rats. J Nutr Biochem. 14:203-210. (Pubitemid 36593459)
31. Nandini CD, Sugahara K. 2006. Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors. Adv Pharamacol. 53:253-279.
32. Pacheco B, Malmstrom A, Maccarana M. 2009. Two dermatan sulfate epi-merases form iduronic acid domains in dermatan sulfate. J Biol Chem. 284:9788-9795.
33. Parasthasarthy N, Sprio R. 1982. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes. 31:738-741.
34. Pecly IMD, Goncalves RG, Rangel EP, Takiya CM, Taboada FS, Martinusso CA, Pavao MS, Leite M, Jr. 2006. Effects of low molecular weight heparin in obstructed kidneys: Decrease of collagen, fibronectin and TGF-β and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration. Nephrol Dial Transplant. 21:1212-1222.
35. Penc SF, Pomaha B, Winkler T, Dorschner RA, Eriksson E, Herndoni M, Gallo RL. 1998. Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. J Biol Chem. 273:28116-28121. (Pubitemid 28496107)
36. Purushothaman A, Fukuda J, Mizumoto S, ten Dam GB, van Kuppevelt TH, Kitagawa H, Mikami T, Sugahara K. 2007. Functions of chondroitin sulfate/dermatan sulfate chains in brain development. Critical roles of E and iE disaccharide units recognized by a single chain antibody GD3G7. J Biol Chem. 282:19442-19452. (Pubitemid 47100083)
37. Rolls A, Cahalon L, Bakalash S, Avidan H, Lider O, Schwartz M. 2006. A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation associated neurodegeneration. FASEB J. 20:547-549. (Pubitemid 46671245)
38. Saito H, Yamagata T, Suzuki S. 1968. Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J Biol Chem. 243:1536-1542.
39. Saraswathi S, Vasan NS. 1983. Alterations in the rat renal glycosaminogly-cans in streptozotocin-induced diabetes. Biochim Biophys Acta. 755:237-243. (Pubitemid 13153880)
40. Schaefer L, Macakova K, Raslik I, Micegova M, Grone HJ, Schonherr E, Robenek H, Echtermeyer FG, Grassel S, Bruckner P, et al. 2002. Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol. 16:1181-1191. (Pubitemid 34224603)
41. Schaefer L, Raslik I, Grone HJ, Schonherr E, Macakova K, Ugorcakova J, Budny S, Schaefer RM, Kresse H. 2001. Small proteoglycans in human diabetic nephropathy: Discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J. 15:559-561.
42. Scott JE. 1960. Aliphatic ammonium salts in the assay of acidic polysacchar-ides from tissues. Methods Biochem Anal. 8:145-197.
43. Sharma K, Ziyadeh FN. 1995. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes. 44:1139-1146.
44. Shipp EL, Hsieh-Wilson LC. 2007. Profiling the sulfation specificities of gly-cosaminoglycan interactions with growth factors and chemotactic proteins using microarrays. Chem Biol. 14:195-208. (Pubitemid 46274428)
45. Shively JE, Conrad HE. 1976. Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry. 15:3932-3942.
46. Silbert JE, Sugumaran G. 2002. Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life. 54:177-186. (Pubitemid 36008326)
47. Stamatoglou SC, Keller JM. 1982. Interaction of cellular glycosaminoglycans with plasma fibronectin and collagen. Biochim Biophys Acta. 719:90-97. (Pubitemid 13223074)
48. Steer DL, Shah MM, Bush KT, Stuart RO, Sampogna RV, Meyer TN, Schwesinger C, Bai X, Esko JD, Nigam SK. 2004. Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney. Dev Biol. 272:310-327. (Pubitemid 38988259)
49. Tamsma JT, Van den Born J, Bruijn JA, Asssmann KJ, Weening JJ, Berden JH, Wieslander J, Schrama E, Hermans J, Veerkamp JH. 1994. Expression of glomerular extracellular matrix components in human diabetic nephropa-thy: Decreases in heparan sulfate in the glomerular basement membrane. Diabetologia. 37:313-320. (Pubitemid 24076085)
50. Tiedemann K, Olander B, Eklund E, Todorova L, Bengtsson M, Maccarana M, Westergren-Thorsson G, Malmstrom A. 2005. Regulation of the chon-droitin/ dermatan fine structure by transforming growth factor-β1 through effects on polymer-modifying enzymes. Glycobiology. 15:1277-1285. (Pubitemid 41724332)
51. Tsilibary EC, Koliakos GG, Charonis AS, Vogel AM, Reger LA, Furchts LT. 1988. Heparin type IV collagen interactions: Equilibrium binding and inhibition of type IV collagen self-assembly. J Biol Chem. 263:19112-19118. (Pubitemid 19016377)
52. Umehara Y, Yamada S, Nishimura S, Shioib J, Robakis NK, Sugahara K. 2004. Chondroitin sulfate of appican, the proteoglycan form of amyloid precursor protein, produced by C6 glioma cells interacts with heparin-binding neuroregulatory factors. FEBS Lett. 557:233-238. (Pubitemid 38115901)
53. Uyama T, Ishida M, Izumikawa T, Trybala E, Tufaro F, Bergstrom T, Sugahara K, Kitagawa H. 2006. Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide expression of chondroitin sulfate required for herpes simplex virus infectivity. J Biol Chem. 281:38668-38674. (Pubitemid 46041992)
54. Wijnhoven TJ, Lensen JF, Wismans RG, Lamrani M, Monnens LA, Wevers RA, Rops AL, van der Vlag J, Berden JH, van den Heuvel LP, et al. 2007. In vivo degradation of heparan sulfates in the glomeru-lar basement membrane does not result in proteinuria. J Am Soc Nephrol. 18:823-832. (Pubitemid 46434499)
55. Williams KJ, Qiu G, Usui HK, Dunn SR, McCue P, Bottinger E, Iozzo RV, Sharma K. 2007. Decorin deficiency enhances progressive nephropathy in diabetic mice. Am J Pathol. 171:1441-1450. (Pubitemid 350158306)
56. Xiong J, Wang Y, Zhu Z, Liu J, Wang Y, Zhang C, Hammes HP, Lang F, Feng Y. 2007. NG2 proteoglycan increases mesangial cell proliferation and extracellular matrix production. Biochem Biophys Res Commun. 361:960-967. (Pubitemid 47259029)
57. Yamaguchi M, Nishida Y, Moriuchi T, Hirose F, Hui CC, Suzuki Y, Matsukage A. 1990. Drosophila proliferating cell nuclear antigen (cyclin) gene: Structure, expression during development, and specific binding of homeodo-main proteins to its 5′-flanking region. Mol Cell Biol. 10:872-879.